Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ryogo Hayashi"'
Autor:
Naomi Kitamoto, Katsumi Itoh, Takashi Ichikawa, Ryogo Hayashi, Yuji Iizawa, Kenji Okonogi, Tomoyuki Kitazaki
Publikováno v:
Antimicrobial Agents and Chemotherapy. 46:283-287
TAK-457 is an injectable prodrug of TAK-456, which is a novel oral triazole compound with potent antifungal activity. The in vivo efficacy of TAK-457 was evaluated in two models of invasive pulmonary aspergillosis with CDF1mice and CBA/J mice with tr
Autor:
Takashi Ichikawa, Masami Yamada, Yoshihiro Matsushita, Tomoyuki Kitazaki, Kenji Okonogi, Ryogo Hayashi, Yutaka Kiyota, Masashi Yamaguchi, Katsumi Itoh
Publikováno v:
Chemical and Pharmaceutical Bulletin. 49:1102-1109
1-[(1R, 2R)-2-(2, 4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl)propyl]-3-[4-(1H-1-tetrazolyl)phenyl]-2-imidazolidinone (1: TAK-456) was selected as a candidate for clinical trials, but since its water-solubility was insufficient fo
Autor:
Ryogo Hayashi, Tomoyuki Kitazaki, Yoshihiro Matsushita, Kenji Okonogi, Akihiro Tasaka, Hiroshi Hosono, Takashi Ichikawa, Katsumi Itoh
Publikováno v:
Chemical and Pharmaceutical Bulletin. 48:1935-1946
New optically active antifungal azoles, N-14-(azolyl)phenyl]- and N-14-(azolylmethyl)phenyl]-N'-[(IR,2R)-2(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(IH-1,2,4-triazol-1-yl)propyllazolones (1, 2, 3), were prepared in a stereocontrolled manner. Compound
Autor:
Tomoyuki Kitazaki, Katsumi Itoh, Ryogo Hayashi, Norikazu Tamura, Hiroshi Hosono, Yoshihiro Matsushita, Kenji Okonogi, Akihiro Tasaka
Publikováno v:
Chemical and Pharmaceutical Bulletin. 47:351-359
New optically active antifungal azoles, 1-[(1R,2R)-2-(2,4-difluoro- and 2-fluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl ]-3-(4- substituted phenyl)-2(1H,3H)-imidazolones (1,2) and 2-imidazolidinones (3,4), were prepared in a stereo
Autor:
Norikazu Tamura, Tomoyuki Kitazaki, Ryogo Hayashi, Katsumi Itoh, Kenji Okonogi, Yoshihiro Matsushita, Akihiro Tasaka
Publikováno v:
Chemical and Pharmaceutical Bulletin. 44:314-327
A new series of optically active antifungal azoles, N-[(1R, 2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl)propyl]-N'-(4-substituted phenyl)-3(2H, 4H)-1, 2, 4-triazolones (1, 2) and 5(1H, 4H)-tetrazolones (3), were prepared
Publikováno v:
Infection and Immunity. 62:4534-4541
Mixed urinary tract infection was caused by simultaneous inoculation of 10(4) CFU each of Enterococcus faecalis TN2005 and Pseudomonas aeruginosa P9 into the bladders of CBA/J mice. Both organisms proliferated in the kidneys, and viable cell counts o
Autor:
Akihiro TASAKA, Katsunori TERANISHI, Yoshihiro MATSUSHITA, Norikazu TAMURA, Ryogo HAYASHI, Kenji OKONOGI, Katsumi ITOH
Publikováno v:
Chemical and Pharmaceutical Bulletin. 42:85-94
Autor:
Katsumi Itoh, Kenji Okonogi, Akihiro Tasaka, Yoshihiro Matsushita, Norikazu Tamura, Ryogo Hayashi, Katsunori Teranishi
Publikováno v:
Chemical and Pharmaceutical Bulletin. 41:1043-1048
In an effort to find potent antifungal agents, a variety of optically active triazole derivatives with a polysulfide structure, 3, 4 and 5, were prepared and evaluated for antifungal activity against Candida albicans in vitro and in vivo. The symmetr
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:100-105
The therapeutic effect of cefozopran (SCE-2787), a new semisynthetic parenteral cephalosporin, against experimental infections in mice was examined. Cefozopran was more effective than cefpiramide and was as effective as ceftazidime and cefpirome agai
Autor:
Katsunori Teranishi, Norikazu Tamura, Katsumi Itoh, Yoshihiro Matsushita, Kenji Okonogi, Ryogo Hayashi, Akihiro Tasaka
Publikováno v:
Chemical and Pharmaceutical Bulletin. 41:1035-1042
(2R,3R)-2-(2,4-Difluorophenyl)-3-mercapto-1-(1H-1,2,4-triazol-1-yl )-2-butano l [(2R,3R)-7] and its stereoisomers [(2S,3R)-, (2S,3S)- and (2R,3S)-7] were prepared from the optically active oxiranes 6 by a newly developed ring-opening reaction and eva